A detailed history of Truvestments Capital LLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 490 shares of EPIX stock, worth $98. This represents 0.0% of its overall portfolio holdings.

Number of Shares
490
Previous 3,688 86.71%
Holding current value
$98
Previous $6,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$0.19 - $1.93 $607 - $6,172
-3,198 Reduced 86.71%
490 $0
Q1 2025

May 14, 2025

SELL
$1.53 - $1.95 $387 - $493
-253 Reduced 6.42%
3,688 $5,000
Q4 2024

Feb 07, 2025

BUY
$1.4 - $6.23 $4,333 - $19,281
3,095 Added 365.84%
3,941 $7,000
Q3 2024

Nov 13, 2024

BUY
$4.45 - $7.1 $3,764 - $6,006
846 New
846 $5,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $8.81M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.